Free tool
Heavily traded stocks
We cover 51 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.44B. Across the group, the median move over the past trading day is +0.23%. 94% of the 51 with a 200-day average trade above it. Price change over the past year runs from −23.8% to +357.4% across the middle 80 percent of the group, with a median of +40.0%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
51 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| 4588.T | Oncolys BioPharma Inc. | $753.78M | Small cap | +539.50% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| 219A.T | HEARTSEED INC | $350.89M | Small cap | −30.13% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| 6078.T | Value HR Co.,Ltd. | $273.03M | Small cap | +6.39% |
| 4820.T | EM Systems Co., Ltd. | $262.55M | Small cap | −18.79% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | $244.15M | Small cap | +14.45% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| 4584.T | Kidswell Bio Corporation | $55.44M | Micro cap | −26.03% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.76% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.